We thank Drs Taylor-Zapata and Mattison for their interest in our article. We also appreciate their clarification of the role of the National Institutes of Health and, more specifically, that of the National Institute of Child Health and Human Development in implementing the Best Pharmaceuticals for Children Act. We believe that these and other initiatives mentioned by the authors are critical to facilitate safe and effective prescribing for children.
Shah SS, Hall M, Slonim AD. Making Progress for How Medicines Are Used in Children—Reply. Arch Pediatr Adolesc Med. 2007;161(9):916–917. doi:10.1001/archpedi.161.9.916-b
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: